Evidence map›Paper›PMID 22050030›Full record

Trial reportAddiction (Abingdon, England)2012

Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.

Matthew G Kirkpatrick, Erik W Gunderson, Chris-Ellyn Johanson, Frances R Levin, Richard W Foltin, Carl L Hart

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Addiction (Abingdon, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 4 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 4 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.The Cochrane database of systematic reviews · 2013
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Effects of MDMA and Intranasal oxytocin on social and emotional processing.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Trial
  10. Article
  11. Article
  12. Mechanisms underlying methamphetamine-induced disruption of testicular integrity.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Matthew G KirkpatrickDepartment of Psychology, Columbia University, New York, NY, USA.
Erik W Gunderson
Chris-Ellyn Johanson
Frances R Levin
Richard W Foltin
Carl L Hart
Columbia University · USWayne State University · US

Funding

Intranasal Methamphetamine: A Pharmacotherapy ModelR01DA019559 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HART, CARL L. · 2005 to 2009
$2.5M
Clinical and Preclinical Models in Drug Abuse: Training and DevelopmentK05DA031749 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FOLTIN, RICHARD W · 2011 to 2015
$641k
NIDA NIH HHS DA-19559NIDA NIH HHS K05 DA031749NIDA NIH HHS R01 DA019559
6 · The paper itself

Abstract

aimsThere are no studies directly comparing self-administration of methamphetamine and d-amphetamine by humans. This study compared intranasal methamphetamine- and d-amphetamine self-administration and characterized the mood, performance and physiological effects produced by the drugs.

designA randomized, double-blind, placebo-controlled, cross-over study.

settingAn out-patient research unit at the New York State Psychiatric Institute.

participantsMale recreational methamphetamine users (n = 13). MEASUREMENTS: Five 2-day blocks of sessions were conducted. On the first day of each block, participants 'sampled' a single methamphetamine or d-amphetamine dose (0, 12, 50 mg/70 kg) and a monetary reinforcer ($5 or $20). Amphetamine plasma levels, cardiovascular, mood, and psychomotor performance effects were assessed before drug administration and repeatedly thereafter. On the second day of each block, participants chose between the sampled reinforcers (drug or money).

findingsThere were no significant differences between the drugs on the majority of measures. Under the $5 condition, both amphetamines increased self-administration dose-dependently, with 41% drug choices overall. Under the $20 condition, only 17% drug options were selected. Both drugs increased cardiovascular activity and 'positive' mood, although methamphetamine produced more prominent effects on some measures (e.g. heart rate and ratings of 'high').

conclusionsMethamphetamine and d-amphetamines appear to produce a similar dose-related profile of effects in humans, which supports their equivalence for abuse potential.

Indexed as

Administration, IntranasalAdultAmbulatory CareAmphetamine-Related DisordersCardiovascular DiseasesCentral Nervous System StimulantsCross-Over StudiesDextroamphetamineDose-Response Relationship, DrugDouble-Blind MethodHumansMaleMethamphetamineNew YorkPsychomotor DisordersSelf AdministrationCentral Nervous System StimulantsDextroamphetamineMethamphetamine

Identifiers

PMID22050030
PMCPMC3475187
OpenAlexW1499607736

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.